Selver Işık

12PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMedical mycologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 15, 2026
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies.

|Mar 28, 2026
Prognostic Impact of Early Metabolic Response on Interim 18F-FDG PET/CT in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

Vali Aliyev, Ali Kaan Güren, Murad Guliyev

|Jan 28, 2026
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma.

Burak Paçacı, Erkam Kocaaslan, Ahmet Demirel

|Jan 28, 2026
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab.

Erkam Kocaaslan, Ali Kaan Güren, Fırat Akagündüz

|Jan 28, 2026
Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab.

Erkam Kocaaslan, Ali Kaan Güren, Fırat Akagündüz

|Jan 28, 2026
Adult-Onset Diffuse Midline Glioma, H3K27-Altered: A Genomics-Guided, Individualized, Multimodal Treatment Approach.

Abdussamet Çelebi, Bilal Yıldırım, Emine Yıldırım

Pageof 2

Frequent Collaborators

8 joint publications

Murat Sarı

7 joint publications

Ali Kaan Güren

7 joint publications

İbrahim Vedat Bayoğu

6 joint publications

Abdussamet Çelebi